GE Healthcare Technologies Inc
gehealthcare.comGE HealthCare Technologies Inc. (NASDAQ: GEHC) is a medical technology company that develops, manufactures, and services advanced imaging systems, patient care solutions, pharmaceutical diagnostics, and AI-enabled software for hospitals and healthcare providers worldwide. Revenue comes from two streams: product sales ($13,661 million in FY2025, 66% of total revenues) and services ($6,964 million in FY2025, 34% of total revenues), totaling $20,625 million for FY2025. The company operates four reporting segments: Imaging ($9,245 million in FY2025), Advanced Visualization Solutions (AVS, $5,354 million), Patient Care Solutions (PCS, $3,086 million), and Pharmaceutical Diagnostics (PDx, $2,900 million). GEHC serves customers in over 160 countries and employs approximately 54,000 people, including roughly 9,700 field service engineers and related service staff. Operating income was $2,763 million (13.4% of total revenues) in FY2025. The company spun off from General Electric and has served patients and providers for nearly 130 years.
Products & Services
Medical imaging systems, advanced visualization software, patient care monitoring equipment, pharmaceutical diagnostic agents, AI-enabled cloud and software solutions, and field service and repair offerings delivered through a global network of field service engineers, repair centers, and customer service centers.
Revenue Model
Transactional product sales of medical devices and consumables combined with recurring service contracts; AI-enabled cloud and software solutions sold separately. Product sales generated $13,661 million and service sales generated $6,964 million in FY2025 (per 10-K filed 2026-02-04).
Customers & Markets
Hospitals, clinicians, and healthcare providers across more than 160 countries. End markets include diagnostic imaging, patient monitoring, pharmaceutical diagnostics, and digital health software.
Geographic Exposure
Global, with customers in over 160 countries as of the FY2025 10-K filing. The filing identifies China and Russia as geographies with localization requirements that create incremental regulatory and market-share risk.
Loading...
